Discovered at McMaster, the newly identified antibiotic presents a potential new therapy for individuals living with Crohn's ...

Johnson & Johnson today launched the Dual Control campaign in Asia Pacific to raise awareness about the importance of ...

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...

Researchers develop enterololin, a new antibiotic that selectively targets harmful gut bacteria, aided by AI model DiffDock.

New research may help improve the lives of those living with IBD. Inflammatory Bowel Disease affects as many as three million Americans and includes ulcerative colitis and Crohn's. Once you have ...

NBC10’s Barbara Morse is sitting down with Dr. Eric Newton, the President of University Gastroenterology along with Renee Ambrose, the Clinical Director of Research. Together, they’re talking about ...

Mahmoud Mosli, Professor of Gastroenterology and Director of the IBD Unit at King Abdulaziz University Hospital in Jeddah, ...

In a groundbreaking study that combines artificial intelligence and laboratory science, researchers have discovered a new ...

Over 300,000 Canadians live with chronic inflammatory bowel diseases (IBD), including Crohn's and ulcerative colitis.

The 28-year-old defender is now supporting IBD research by the Royal Devon University Healthcare NHS Foundation Trust and the ...

A Spanish trial finds similar sustained IBD clinical remission rates 1-year post-withdrawal vs maintenance of anti-TNF ...